Barring Pay-For-Delay, Reverse Payment Settlements

Law360, New York (October 28, 2009, 1:21 PM EDT) -- On Oct. 15, 2009, the Senate Judiciary Committee voted to approve the Preserve Access to Affordable Generic Drugs Act (S.369).

The proposed act is meant to put a stop to pay-for-delay and reverse cash payments that were found to be legal in the Schering Plough Corp. v. Federal Trade Commission and In re Tamoxifen Citrate Antitrust Litig. litigations, and are currently being litigated in the In re Ciprofloxacin Hydrochloride Citrate Antitrust Litig. case.

While no vote on the full bill is scheduled and final legislation is...
To view the full article, register now.